Crystal structures of thrombin with thiazole-containing inhibitors: Probes of the S1' binding site

Biophysical Journal

Volumn 71, Issue 5, 1996, Pages 2830-2839

  Matthews, John H ^a   Krishnan, R ^a   Costanzo, Michael J ^b   Maryanoff, Bruce E ^b   Tulinsky, A ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBIN; THROMBIN INHIBITOR;

ARTICLE; BINDING SITE; CRYSTAL STRUCTURE; PROTEIN BINDING; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

EID: 0029965611     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(96)79479-1     Document Type: Article

References (45)

1. Ayala, Y., and E. DiCera. 1994. Molecular recognition by thrombin. Role of the slow→fast transition, site-specific ion binding energetics and thermodynamic mapping of structural components. J. Mol. Biol. 235: 733-746.
2. Banner, D., and P. Hadvary, 1991. Crystallographic analysis at 3.0-Å resolution of the binding to human thrombin of four active site-directed inhibitors. J. Biol. Chem. 266:20085-20093.
3. Beveridge, D., and F. DiCapua. 1989. Free energy via molecular simulation: applications to chemical and biomolecular systems. Annu. Rev. Biophys. Biophys. Chem. 18:431-492.
4. Blomback, B., M. Blomback, B. Hessel, and S. Iwanaga. 1967. Structure of N-terminal fragments of fibrinogen and specificity of thrombin. Nature. 215:1445-1448.
5. Bode, W., D. Turk, and A. Karshikov. 1992. The refined 1.9-Å X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships. Protein Sci. 1:426-471.
6. Bode, W., D. Turk, and J. Sturzebecher. 1990. Geometry of binding of the benzamidine- and arginine-based inhibitors NAPAP and MQPA to human alpha-thrombin. X-ray crystallographic determination of the NAPAP-trypsin complex and modeling of NAPAP-thrombin and MQPA-thrombin. Eur. J. Biochem. 193:175-182.
7. Brandstetter, H., D. Turk, H. W. Hoeffken, D. Grosse, J. Sturzebecher, P. D. Martin, B. F. P. Edwards, and W. Bode. 1992. Refined 2.3 Å X-ray crystal structure of bovine thrombin complexes formed with the benzamidine- and arginine-based thrombin inhibitors NAPAP, 4-TAPAP, and MQPA: a starting point for improving antithrombotics. J. Mol. Biol. 226:1085-1099.
8. Burley, S. K., and G. A. Petsko. 1985. Aromatic-aromatic interaction: a mechanism of protein stabilization. Science. 229:23-28.
9. Costanzo, M. J., L. R. Hecker, M. R. Schott, S. C. Yabut, H. C. Zang, P. Andrade-Gordon, J. A. Kauffman, J. M. Lewis, R. Krishnan, A. Tulinsky, and B. E. Maryanoff. 1996. Potent thrombin inhibitors that probe the S1′ subsite. J. Med. Chem. 39:3039-3043.
10. Davie, E. W., K. Fujikawa, and W. Kisiel. 1991. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry. 30:10363-10370.
11. + binding site of thrombin. J. Biol. Chem. 270:22089-22092.
12. DiMaio, J., B. Gibbs, Y. Konishi, J. Lefebre, and D. Munn. 1992. Synthesis of a homologous series of ketomethylene arginyl pseudodipeptides and applications to low molecular weight hirudin-like thrombin inhibitors. J. Med. Chem. 35:3331-3341.
13. Edwards, P. D., E. F. Meyer, Jr., J. Vijayalakshmi, P. A. Tuthill, D. A. Andisik, B. Gomes, and A. Strimpler. 1992. Design, synthesis, and kinetic evaluation of a unique class of elastase inhibitors, the peptidyl alpha-ketobenzoxazoles, and the X-ray crystal structure of the covalent complex between porcine pancreatic elastase and Ac-Ala-Pro-Val-2-benzoxazole. J. Am. Chem. Soc. 114:1854-1863.
14. Esmon, C. T. 1989. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J. Biol. Chem. 264:4743-4746.
15. Esmon, N. L., W. G. Owen, and C. T. Esmon. 1982. Isolation of membrane-bound cofactor for thrombin-catalyzed activation of protein C. J. Biol. Chem. 257:859-864.
16. Finzel, B. C. 1987. Incorporation of fast Fourier transforms to speed restrained least-squares refinement of protein structures. J. Appl. Crystallogr. 20:53-55.
17. Grutter, M. G., J. P. Priestle, J. Rahuel, H. Grossenbacher, W. Bode, J. Hofsteenge, and S. R. Stone. 1990. Crystal structure of thrombin-hirudin complex: a novel mode of serine protease inhibitor. EMBO J. 9:2361-2365.
18. Hendrickson, W. A. 1985. Stereochemically restrained refinement of macromolecular structure. Methods Enzymol. 115:252-270.
19. Higashi, T. 1990. Auto-indexing of oscillation images. J. Appl. Crystallogr. 23:253-257.
20. Hijikata, A., S. Okamoto, E. Mori, K. Kinjo, R. Kikumoto, S. Tonomura, Y. Tamao, and H. Hara. 1976. In vitro and in vivo studies of a new series of synthetic thrombin-inhibitors (om-inhibitors). Thromb. Res. Suppt. 2. 8:83-89.
21. Hogg, D. H., and B. Blomback. 1978. The mechanism of the fibrinogenthrombin reaction. Thromb. Res. 12:953-964.
22. Howard, A. J., G. L. Gilliland, B. C. Finzel, T. L. Poulos, D. H. Ohlendorf, and F. R. Salemme. 1987. The use of an imaging proportional counter in macromolecular crystallography. J. Appl. Crystallogr. 20:383-387.
23. Hung, D. T., T. K. H. Vu, V. I. Wheaton, K. Ishii, and S. R. Coughlin. 1992. Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation. J. Clin. Invest. 89:1350-1353.
24. Jackson, C. M., and Y. Nemerson. 1980. Blood coagulation. Annu. Rev. Biochem. 49:765-811.
25. Kikumoto, R., Y. Tamao, K. Ohkubo, T. Tezuka, and S. Tonomura. 1980. Thrombin inhibitors. 2. Amide derivatives of N-alpha-substituted L-arginine. J. Med. Chem. 23:830-836.
26. 2-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl) sulfonyl]-L-arginyl)]-2-piperidinecarboxylic acid. Biochemistry. 23: 85-90.
27. Krishnan, R., A. Tulinsky, G. P. Vlasuk, D. Pearson, P. Vallar, P. Bergum, T. K. Brunck, and W. C. Ripka. 1996. Synthesis, structure, and structure-activity relationships of divalent thrombin inhibitors containing an alpha-ketoamide transition state mimetic. Protein Sci. 5:422-433.
28. Lottenberg, R., J. A. Hall, M. Blinder, E. P. Binder, and C. M. Jackson. 1983. The action of thrombin on peptide p-nitroanilide substrates. Substrate selectivity and examination of hydrolysis under different reaction conditions. Biochim. Biophys. Acta. 742:539-557.
29. Marsh, H. C., Y. C. Meinwald, T. W. Thannhauser, and H. A. Scheraga. 1983. Mechanism of action of thrombin on fibrinogen. Kinetic evidence for involvement of aspartic acid at position P10. Biochemistry. 22: 4170-4174.
30. Mathews, I. I., K. P. Padmanabhan, V. Ganesh, A. Tulinsky, M. Ishii, J. Chen, C. W. Turck, S. R. Coughlin, and J. W. Fenton, II. 1994. Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes. Biochemistry. 33:3266-3279.
31. Mathews, I. I., and A. Tulinsky. 1995. Active site mimetic inhibition of thrombin. Acta Crystallogr. D51:550-559.
32. Nesheim, M. E., F. G. Prendergast, and K. G. Mann. 1979. Interactions of a fluorescent active-site-directed inhibitor of thrombin: dansylarginine N-(3-ethyl-1,5-pentanediyl)amide. Biochemistry. 18:996-1003.
33. Okamoto, S., A. Hijikata, K. Ikezawa, K. Kinjo, R. Kikumoto, S. Tonomura, and Y. Tamao. 1976. A new series of synthetic thrombin-inhibitors (OM-inhibitors) having extremely potent and selective action. Thromb. Res. Suppl. 2. 8:77-82.
34. Qiu, X., K. P. Padmanabhan, V. E. Carperos, A. Tulinsky, T. Kline, J. M. Maraganore, and J. W. Fenton, II. 1992. Structure of the hirulog 3-thrombin complex and nature of the S′ subsites of substrates and inhibitors. Biochemistry. 31:11689-11697.
35. Rydel, T. J., K. G. Ravichandran, A. Tulinsky, W. Bode, R. Huber, C. Roitsch, and J. W. Fenton, II. 1990. The structure of a complex of recombinant hirudin and human alpha-thrombin. Science. 249:277-280.
36. Rydel, T. J., A. Tulinsky, W. Bode, and R. Huber. 1991. Refined structure of the hirudin-thrombin complex. J. Mol. Biol. 221:583-601.
37. Singh, J., J. M. Thornton, M. Snarey, and S. F. Campbell. 1987. The geometries of interacting arginine-carboxyls in proteins. FEBS Lett. 224:161-171.
38. Skrzypczak-Jankun, E., V. E. Carperos, K. G. Ravichandran, A. Tulinsky, M. Westbrook, and J. M. Maraganore. 1991. Structure of the hirugen and hirulog 1 complexes of alpha-thrombin. J. Mol. Biol. 221:1379-1393.
39. Stubbs, M. T., and W. Bode. 1993. A player of many parts: the spotlight falls on thrombin's structure. Thromb. Res. 69:1-58.
40. Tabernero, L., C. Y. Chang, S. L. Ohringer, W. F. Lau, E. J. Iwanowicz, W.-C. Han, T. C. Wang, S. M. Seiler, D. G. M. Roberts, and J. S. Sack. 1995. Structure of a retro-binding peptide inhibitor complexed with human alpha-thrombin. J. Mol. Biol. 246:14-20.
41. Tulinsky, A., and X. Qiu. 1993. Active site and exosite binding of alpha-thrombin. Blood Coag. Fibrin. 4:305-312.
42. Turk, D., J. Sturzebecher, and W. Bode. 1991. Geometry of binding of alpha-tosylated piperidines of m-amidino, p-amidino- and p-guanidino phenylalanine to thrombin and trypsin. X-ray crystal structures of their trypsin complexes and modeling of their thrombin complexes. FEBS Lett. 287:133-138.
43. Vijayalakshmi, J., K. P. Padmanabhan, K. G. Mann, and A. Tulinsky. 1994. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin. Protein Sci. 3:2254-2271.
44. Wu, Q., J. P. Sheehan, M. Tsiang, S. R. Lentz, J. J. Birktoft, and J. E. Sadler. 1991. Single amino acid substitutions dissociate fibrinogen-clotting and thrombomodulin-binding activities of human thrombin. Proc. Natl. Acad. Sci. USA. 88:6775-6779.
45. Zdanov, A., S. Wu, J. DiMaio, Y. Konishi, Y. Li, X. Wu, B. F. P. Edwards, P. D. Martin, and M. Cygler. 1993. Crystal structure of the complex of human alpha-thrombin and non-hydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6. Proteins. 17:252-265.